Literature DB >> 22551249

Heterotropic cooperativity within and between protomers of an oligomeric M(2) muscarinic receptor.

Rabindra V Shivnaraine1, Xi-Ping Huang, Margaret Seidenberg, John Ellis, James W Wells.   

Abstract

At least four allosteric sites have been found to mediate the dose-dependent effects of gallamine on the binding of [(3)H]quinuclidinylbenzilate (QNB) and N-[(3)H]methylscopolamine (NMS) to M(2) muscarinic receptors in membranes and solubilized preparations from porcine atria, CHO cells, and Sf9 cells. The rate of dissociation of [(3)H]QNB was affected in a bell-shaped manner with at least one Hill coefficient (n(H)) greater than 1, indicating that at least three allosteric sites are involved. The level of binding of [(3)H]QNB was decreased in a biphasic manner, revealing at least two allosteric sites; binding of [(3)H]NMS was affected in a triphasic, serpentine manner, revealing at least three sites, and values of n(H) >1 pointed to at least four sites. Several lines of evidence indicate that all effects of gallamine were allosteric in nature and could be observed at equilibrium. The rates of equilibration and dissociation suggest that the receptor was predominately oligomeric, and the heterogeneity revealed by gallamine can be attributed to differences in its affinity for the constituent protomers of a tetramer. Those differences appear to arise from inter- and intramolecular cooperativity between gallamine and the radioligand.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22551249      PMCID: PMC3595096          DOI: 10.1021/bi3000287

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  72 in total

Review 1.  Allosteric modulation of G protein-coupled receptors.

Authors:  Lauren T May; Katie Leach; Patrick M Sexton; Arthur Christopoulos
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

2.  Two-state models and the analysis of the allosteric effect of gallamine at the M2 muscarinic receptor.

Authors:  Frederick J Ehlert; Michael T Griffin
Journal:  J Pharmacol Exp Ther       Date:  2008-02-27       Impact factor: 4.030

3.  Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins.

Authors:  Timothy H Bayburt; Andrew J Leitz; Guifu Xie; Daniel D Oprian; Stephen G Sligar
Journal:  J Biol Chem       Date:  2007-03-29       Impact factor: 5.157

4.  Detection of heteromerization of more than two proteins by sequential BRET-FRET.

Authors:  Paulina Carriba; Gemma Navarro; Francisco Ciruela; Sergi Ferré; Vicent Casadó; Luigi Agnati; Antoni Cortés; Josefa Mallol; Kjell Fuxe; Enric I Canela; Carmen Lluís; Rafael Franco
Journal:  Nat Methods       Date:  2008-06-29       Impact factor: 28.547

5.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein.

Authors:  Matthew R Whorton; Michael P Bokoch; Søren G F Rasmussen; Bo Huang; Richard N Zare; Brian Kobilka; Roger K Sunahara
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

6.  Heterooligomers of the muscarinic receptor and G proteins purified from porcine atria.

Authors:  Amy W-S Ma; Asha B Pawagi; James W Wells
Journal:  Biochem Biophys Res Commun       Date:  2008-07-02       Impact factor: 3.575

7.  Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles.

Authors:  Amy W-S Ma; Dar'ya S Redka; Luca F Pisterzi; Stéphane Angers; James W Wells
Journal:  Biochemistry       Date:  2007-06-07       Impact factor: 3.162

8.  Cholesterol as a determinant of cooperativity in the M2 muscarinic cholinergic receptor.

Authors:  Alejandro T Colozo; Paul S-H Park; Chi Shing Sum; Luca F Pisterzi; James W Wells
Journal:  Biochem Pharmacol       Date:  2007-04-13       Impact factor: 5.858

9.  Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.

Authors:  Dar'ya S Redka; Luca F Pisterzi; James W Wells
Journal:  Mol Pharmacol       Date:  2008-06-13       Impact factor: 4.436

10.  The alpha1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function.

Authors:  Juan F Lopez-Gimenez; Meritxell Canals; John D Pediani; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2007-01-12       Impact factor: 4.436

View more
  6 in total

1.  Ligand-Induced Coupling between Oligomers of the M2 Receptor and the Gi1 Protein in Live Cells.

Authors:  Yuchong Li; Rabindra V Shivnaraine; Fei Huang; James W Wells; Claudiu C Gradinaru
Journal:  Biophys J       Date:  2018-08-08       Impact factor: 4.033

Review 2.  Muscarinic acetylcholine receptors: novel opportunities for drug development.

Authors:  Andrew C Kruse; Brian K Kobilka; Dinesh Gautam; Patrick M Sexton; Arthur Christopoulos; Jürgen Wess
Journal:  Nat Rev Drug Discov       Date:  2014-06-06       Impact factor: 84.694

3.  Oligomerization of yeast α-factor receptor detected by fluorescent energy transfer between ligands.

Authors:  Sara M Connelly; Rajashri Sridharan; Fred Naider; Mark E Dumont
Journal:  Biophys J       Date:  2021-10-08       Impact factor: 4.033

4.  Allosteric modulation in monomers and oligomers of a G protein-coupled receptor.

Authors:  Rabindra V Shivnaraine; Brendan Kelly; Krishana S Sankar; Dar'ya S Redka; Yi Rang Han; Fei Huang; Gwendolynne Elmslie; Daniel Pinto; Yuchong Li; Jonathan V Rocheleau; Claudiu C Gradinaru; John Ellis; James W Wells
Journal:  Elife       Date:  2016-05-06       Impact factor: 8.140

Review 5.  Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors.

Authors:  Wessel A C Burger; Patrick M Sexton; Arthur Christopoulos; David M Thal
Journal:  J Gen Physiol       Date:  2018-09-06       Impact factor: 4.086

6.  Allostery of atypical modulators at oligomeric G protein-coupled receptors.

Authors:  Rabindra V Shivnaraine; Brendan Kelly; Gwendolynne Elmslie; Xi-Ping Huang; Yue John Dong; Margaret Seidenberg; James W Wells; John Ellis
Journal:  Sci Rep       Date:  2021-04-29       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.